INTRODUCTION {#s1}
============

Irritable bowel syndrome (IBS) is the most prevalent gastrointestinal disorder characterized by abdominal discomfort, pain, and altered defecation patterns; it may considerably reduce patients' quality of life and work productivity, which affects more than 7 percent of people all around the world \[[@R1], [@R2]\]. According to the recurrent symptoms, IBS patients can experience constipation (IBS-C), diarrhea (IBS-D), mixture of diarrhea and constipation IBS (IBS-M) and un-subtyped IBS \[[@R3], [@R4]\]. IBS is a multifactorial disorder that is associated with biological and psychosocial factors \[[@R5]--[@R7]\]. Although genetic predisposition has been demonstrated in classical family and twin studies, unequivocal susceptibility genes have yet to be identified \[[@R2], [@R8]\]. Recently, several genetic association studies identified the guanine nucleotide binding protein (G-protein) *β3* subunit gene (*GNβ3*) C825T polymorphism as being significantly associated with IBS \[[@R9]--[@R12]\].

G-protein, consisting of an α, β, and γ subunit, is an intracellular second messenger signalling protein linked to a transmembrane receptor \[[@R13], [@R14]\]. The C825T polymorphism of *GNβ3* (rs5443) is associated with alternative splicing of the gene and its protein activity, and an increased intracellular signal transduction compared with unmodified Gβ3 protein \[[@R15], [@R16]\]. This single nucleotide polymorphism (SNP) has been reported to be associated with depression \[[@R17]\], Alzheimer\'s disease (AD) \[[@R18]\], hypertension \[[@R19]\], obesity \[[@R20]\], Insulin-mediated venodilation \[[@R21]\], Vasculogenic erectile dysfunction (VED) \[[@R22]\], and functional dyspepsia \[[@R23]\]. Recently, the association between the *GNβ3 C825T* polymorphism and the risk of IBS has been intensively investigated. However, the community is still unable to reach a consensus, particularly regarding the data from different ethnicities and IBS subtypes \[[@R9]--[@R12], [@R24]--[@R30]\]. To date, only one meta-analyses has reported on the relationship between *GNβ3* C825T polymorphism and susceptibility to IBS \[[@R31]\]. However, that meta-analysis only included seven studies, and missed many published articles \[[@R27]--[@R30]\]. Moreover, the previous meta-analysis did not analyze the association between *GNβ3* C825T polymorphism and different IBS subtypes with respect to ethnicity. Therefore, we conducted an updated meta-analysis including all published studies accompanied with ethnic subgroup analyses and IBS subtype analyses to clarify whether *GNβ3* C825T was associated with the development of IBS and its subtypes.

RESULTS {#s2}
=======

Characteristics of studies 26-9-11 {#s2_1}
----------------------------------

As showed in Figure [1](#F1){ref-type="fig"}, eleven studies involving 1,422 cases and 2,073 controls were ultimately included in the present meta-analysis, and eight of them \[[@R10], [@R12], [@R24], [@R25], [@R27]--[@R30]\] specifically investigated the association between *GNβ3* C825T polymorphism and different IBS subtypes (including the IBS-C, IBS-D and IBS-M) risk. The main characteristics of the included articles were summarized in Table [1](#T1){ref-type="table"}. All of these included articles were case-control studies, of which nine in a hospital-based design \[[@R10]--[@R12], [@R25]--[@R30]\], two in a population-based design \[[@R9], [@R24]\]. Among these studies, six were on Caucasians \[[@R9], [@R11], [@R24], [@R25], [@R27], [@R28]\] and the other five were on Asians \[[@R10], [@R12], [@R26], [@R29], [@R30]\]. Additionally, all of the included studies were of high quality, as indicated by the Newcastle-Ottawa scale (NOS) scores of each study being above 6 points, and the genotype distributions in all of the controls were consistent with Hardy-Weinberg equilibrium (HWE), except one \[[@R10]\]. Studies with controls not in HWE were also considered for the meta-analysis, but they were excluded in the sensitivity analysis.

![Flow diagram of selection of eligible studies](oncotarget-09-2770-g001){#F1}

###### Characteristics of studies included in the meta-analysis

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                Country         Ethnicity    Design   Gender\         Genotype distribution (case/control)   Genotyping Method   Diagnosis criteria   HWE (P)                                     NOS               
                                                             (M:F \[n\])                                                                                                                                                   
  -------------------- --------------- ------------ -------- --------------- -------------------------------------- ------------------- -------------------- ------------------------------------------- ---------- ------ ---
  Andresen V 2006      United States   Caucasian\   PB       31:183 /\       111/\                                  87/\                16/\                 Direct\                                     Rome II    0.92   9
                                       (95.1%)               40:112          77                                     62                  13                   Sequencing                                                    

  Camilleri M 2008     United States   Caucasian    HB       3:119/ 0:39     57/\                                   53/\                12/\                 Direct\                                     Rome II    0.82   7
                                                                             19                                     16                  4                    Sequencing                                                    

  de Vries DR 2009     Netherlands     Caucasian    PB       66:70 /\        60/\                                   68/\                8/\                  molecular beacon assay                      Rome II    0.10   8
                                                             120:253         199                                    138                 36                                                                                 

  Kim HG 2012          South Korea     Asian        HB       25:35 /\        16/\                                   31/\                13/\                 TaqMan Assay                                Rome III   0.85   7
                                                             167:267         112                                    215                 107                                                                                

  Lee HJ 2010          South Korea     Asian        HB       58:36 /\        13/\                                   49/\                32/\                 PCR and\                                    Rome III   0.01   7
                                                             44:44           16                                     56                  16                   RFLP                                                          

  Markoutsaki T 2011   Greece          Caucasian    HB       30:94/ 96:142   37/ 120                                65/\                22/\                 PCR and\                                    Rome III   0.82   7
                                                                                                                    97                  21                   RFLP                                                          

  Park CS 2012         South Korea     Asian        HB       32:40/ 81:67    27/ 35                                 28/\                17/\                 SNaPShot                                    Rome III   0.41   7
                                                                                                                    79                  34                                                                                 

  Saito YA 2007        United States   Caucasian\   HB       9:41/ 10:43     25/ 24                                 19/\                6/\                  Thermo Electron Hybaid MBS thermal cycler   Rome II    0.59   7
                                       (\> 96%)                                                                     22                  7                                                                                  

  Saito YA 2012        United States   Caucasian\   HB       65:320/\        122/\                                  117/\               28/\                 Thermo Electron Hybaid MBS thermal cycler   Rome II    0.80   7
                                       (\> 97%)              84:178          114                                    109                 28                                                                                 

  Yoon Jin Choi 2014   South Korea     Asian        HB       38:61 / 85:86   26/ 40                                 46 /\               27 /\                TaqMan Assay                                Rome III   0.52   8
                                                                                                                    81                  50                                                                                 

  Yuezhi Wang 2014     China           Asian        HB       56:10/ 89:26    50/ 92                                 13/\                3/\                  Real-Time PCR                               Rome III   0.54   7
                                                                                                                    21                  2                                                                                  
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: HB, hospital-based study; PB, population based; RFLP, restriction fragment length polymorphism analyses

Power analysis {#s2_2}
--------------

Before implementation of this meta-analysis, statistical power was assessed with the assumptions:α err prob = 0.05, OR = 1.25 (corresponding to a "weak to moderate" gene effect) for the SNP, and minor allele frequencies(MAF) of *GNβ3* C825T(rs5443, C/T) was estimated from the 1000 Genomes. The present samples indicated that 100% power to evaluate the association between this polymorphism and IBS. And the power to evaluate the associations between this polymorphism and IBS subtypes (IBS-C, IBS-D and IBS-M) were 88.1%, 98.3% and 93.9%, respectively. The power analysis indicated that these recruited samples could provide sufficient power in identifying the association between *GNβ3* C825T(rs5443, C/T) polymorphism and IBS and its subtypes.

Quantitative synthesis {#s2_3}
----------------------

### *GNβ3* C825T and IBS risk {#s2_3_1}

Overall, no significant association between *GNβ3* C825T polymorphism and risk of IBS was observed under all genetic models (C vs. T, *P* = 0.194; CC vs. TT, *P* = 0.564; CT vs. TT, *P* = 0.594; CC + CT vs. TT, *P* = 0.430; CC vs. CT+TT, *P* = 0.462) (Figure [2](#F2){ref-type="fig"}). In the subgroup analyses by ethnicity, significant associations were not found in any genetic model for Asians and Caucasians. All the results are listed in Table [2](#T2){ref-type="table"}.

![The associations of *GNβ3* C825T with IBS in different genetic models\
(**A**) Allele model (C vs. T). (**B**) Codominant model (CC vs. TT). (**C**) Codominant model (CT vs. TT). (**D**) Dominant model (CC + CT vs. TT). (**E**) Recessive model (CC vs. TT + CT).](oncotarget-09-2770-g002){#F2}

###### Summary of meta-analysis for the association of GNβ3 C825T polymorphism with IBS and its subtypes

  Genetic models     Stratifications   Number of studies   OR (95%CI)               *P* value   Heterogeneity   
  ------------------ ----------------- ------------------- ------------------------ ----------- --------------- -------
  **IBS**                                                                                                       
  **C vs. T**        Overall           11                  0.893 \[0.752, 1.060\]   0.194       54.5%           0.015
                     Asians            5                   0.959 \[0.756, 1.216\]   0.729       37.7%           0.170
                     Caucasian         6                   0.852 \[0.666, 1.091\]   0.205       64.6%           0.015
  **CC vs. TT**      Overall           11                  0.906 \[0.649, 1.266\]   0.564       45.6%           0.049
                     Asians            5                   0.960 \[0.583, 1.580\]   0.872       36.9%           0.175
                     Caucasian         6                   0.879 \[0.543, 1.421\]   0.599       57.0%           0.040
  **CT vs. TT**      Overall           11                  0.940 \[0.748, 1.180\]   0.594       18.4%           0.268
                     Asians            5                   0.800 \[0.578, 1.107\]   0.179       26.0%           0.248
                     Caucasian         6                   1.096 \[0.796, 1.509\]   0.574       5.9%            0.379
  **CC+CT vs. TT**   Overall           11                  0.917 \[0.739, 1.137\]   0.430       31.3%           0.150
                     Asians            5                   0.866 \[0.639, 1.175\]   0.356       38.4%           0.165
                     Caucasian         6                   0.970 \[0.715, 1.316\]   0.845       36.7%           0.162
  **CC vs. CT+TT**   Overall           11                  0.914 \[0.718, 1.162\]   0.462       53.3%           0.018
                     Asians            5                   1.110 \[0.794, 1.552\]   0.542       24.3%           0.259
                     Caucasian         6                   0.814 \[0.595, 1.113\]   0.197       60.8%           0.026
  **IBS-C**                                                                                                     
  **C vs. T**        Overall           8                   0.788 \[0.622, 0.997\]   **0.048**   24%             0.238
                     Asians            4                   0.520 \[0.329, 0.821\]   **0.005**   0%              0.503
                     Caucasian         4                   0.926 \[0.701,1.225\]    0.592       0%              0.461
  **CC vs. TT**      Overall           8                   0.622 \[0.370, 1.046\]   0.073       0%              0.532
                     Asians            4                   0.258 \[0.094, 0.707\]   **0.008**   0%              0.736
                     Caucasian         4                   0.974 \[0.506, 1.877\]   0.938       0%              0.827
  **CT vs. TT**      Overall           8                   0.709 \[0.449, 1.120\]   0.140       0%              0.552
                     Asians            4                   0.431 \[0.221, 0.842\]   **0.014**   0%              0.749
                     Caucasian         4                   1.094 \[0.571, 2.093\]   0.787       0%              0.839
  **CC+CT vs. TT**   Overall           8                   0.653 \[0.422, 1.011\]   0.056       6.4%            0.381
                     Asians            4                   0.378 \[0.200, 0.714\]   **0.003**   0%              0.652
                     Caucasian         4                   1.035 \[0.556, 1.929\]   0.913       0%              0.848
  **CC vs. CT+TT**   Overall           8                   0.835 \[0.597, 1.168\]   0.292       0%              0.731
                     Asians            4                   0.513 \[0.218, 1.208\]   0.126       0%              0.668
                     Caucasian         4                   0.927 \[0.641, 1.340\]   0.686       0%              0.621
  **IBS-D**                                                                                                     
  **C vs. T**        Overall           8                   1.162 \[0.977, 1.381\]   0.089       30.9%           0.181
                     Asians            4                   1.316 \[1.019, 1.700\]   **0.035**   55.8%           0.079
                     Caucasian         4                   1.046 \[0.827, 1.321\]   0.709       0%              0.635
  **CC vs. TT**      Overall           8                   1.246 \[0.866, 1.793\]   0.236       14.8%           0.314
                     Asians            4                   1.609 \[0.963, 2.690\]   0.069       43.9%           0.148
                     Caucasian         4                   0.957 \[0.571, 1.603\]   0.867       0%              0.802
  **CT vs. TT**      Overall           8                   0.843 \[0.592, 1.201\]   0.345       0%              0.822
                     Asians            4                   0.796 \[0.493, 1.287\]   0.352       9.1%            0.348
                     Caucasian         4                   0.902 \[0.543, 1.525\]   0.701       0%              0.979
  **CC+CT vs. TT**   Overall           8                   0.996 \[0.716, 1.384\]   0.980       0%              0.542
                     Asians            4                   1.048 \[0.674, 1.630\]   0.836       43.6%           0.150
                     Caucasian         4                   0.934 \[0.570, 1.529\]   0.785       0%              0.901
  **CC vs. CT+TT**   Overall           8                   1.268 \[1.000, 1.608\]   **0.050**   27.8%           0.206
                     Asians            4                   1.688 \[1.157, 2.463\]   **0.007**   29.2%           0.237
                     Caucasian         4                   1.054 \[0.777, 1.432\]   0.735       0%              0.644
  **IBS-M**                                                                                                     
  **C vs. T**        Overall           8                   0.789 \[0.576, 1.080\]   0.139       51.5%           0.044
                     Asians            4                   0.672 \[0.403, 1.121\]   0.128       50.1%           0.111
                     Caucasian         4                   0.926 \[0.660, 1.299\]   0.655       34.5%           0.205
  **CC vs. TT**      Overall           8                   0.798 \[0.402, 1.587\]   0.521       38.1%           0.126
                     Asians            4                   0.464 \[0.126, 1.713\]   0.249       53.1%           0.094
                     Caucasian         4                   1.253 \[0.678, 2.316\]   0.472       0.0%            0.513
  **CT vs. TT**      Overall           8                   0.994 \[0.662, 1.495\]   0.979       0%              0.614
                     Asians            4                   0.755 \[0.431, 1.325\]   0.327       0%              0.622
                     Caucasian         4                   1.337 \[0.732, 2.440\]   0.345       0%              0.540
  **CC+CT vs. TT**   Overall           8                   0.941 \[0.639, 1.387\]   0.760       11.6%           0.340
                     Asians            4                   0.689 \[0.404, 1.174\]   0.170       9.5%            0.346
                     Caucasian         4                   1.306 \[0.736, 2.318\]   0.361       0.0%            0.529
  **CC vs. CT+TT**   Overall           8                   0.788 \[0.500, 1.240\]   0.303       45.2%           0.078
                     Asians            4                   0.622 \[0.216, 1.789\]   0.378       61.5%           0.050
                     Caucasian         4                   0.935 \[0.623, 1.403\]   0.746       21.6%           0.281

### *GNβ3* C825T and IBS-C risk {#s2_3_2}

The C allele of *GNβ3* C825T was found to be significantly associated with a decreased risk of IBS-C in allele model (C vs. T, OR = 0.788, 95% CI: 0.622-0.997, *P* = 0.048), while no evidence of significance was identified in other genetic models (CC vs. TT, *P* = 0.073; CT vs. TT, *P* = 0.140; CC+CT vs. TT, *P* = 0.056; CC vs. CT+TT, *P* = 0.292). In the subgroup analyses by ethnicity, the significant association was found among Asians under all genetic models (C vs. T, OR = 0.520, 95% CI: 0.329-0.821, *P* = 0.005; CC vs. TT, OR = 0.258, 95% CI: 0.094-0.707, *P* = 0.008; CT vs. TT, OR = 0.431, 95% CI: 0.221-0.842, *P* = 0.014; CC+CT vs. TT, OR = 0.378, 95% CI: 0.200-0.714, *P* = 0.003) except for the recessive model (CC vs. CT+TT, *P* = 0.126) (Figure [3](#F3){ref-type="fig"}). However, there was no significant association between this polymorphism and IBS-C development in the Caucasian population under any genetic model. All the results are listed in Table [2](#T2){ref-type="table"}.

![The associations of *GNβ3* C825T with IBS-C in different genetic models\
(**A**) Allele model (C vs. T). (**B**) Codominant model (CC vs. TT). (**C**) Codominant model (CT vs. TT). (**D**) Dominant model (CC + CT vs. TT). (**E**) Recessive model (CC vs. TT + CT).](oncotarget-09-2770-g003){#F3}

### *GNβ3* C825T and IBS-D risk {#s2_3_3}

The CC genotype of *GNβ3* C825T was found to be significantly associated with an increased risk of IBS-D in recessive model (CC vs. CT + TT, OR = 1.268, 95% CI: 1.000-1.608, *P* = 0.050), while no evidence of significance was identified in other genetic models (C vs. T, *P* = 0.089; CC vs. TT, *P* = 0.236; CT vs. TT, *P* = 0.345; CC + CT vs. TT, *P* = 0.980). In the subgroup analyses by ethnicity, the significant association was found among Asians under allele model (C vs. T, OR = 1.316, 95% CI: 1.019--1.700, *P* = 0.035) and recessive model (CC vs. CT+TT, OR = 1.688, 95% CI: 1.157--2.463, *P* = 0.007), while no evidence of significance was identified in other two genetic models (Figure [4](#F4){ref-type="fig"}). However, there was no significant association between this polymorphism and IBS-D development in the Caucasian population under any genetic model. All the results are listed in Table [2](#T2){ref-type="table"}.

![The associations of *GNβ3* C825T with IBS-D in different genetic models\
(**A**) Allele model (C vs. T). (**B**) Codominant model (CC vs. TT). (**C**) Codominant model (CT vs. TT). (**D**) Dominant model (CC + CT vs. TT). (**E**) Recessive model (CC vs. TT + CT).](oncotarget-09-2770-g004){#F4}

### *GNβ3* C825T and IBS-M risk {#s2_3_4}

No significant association was found between *GNβ3* C825T polymorphism and IBS-M in the overall population. In subgroup analysis, there was no significant association between this polymorphism and IBS-M development in the Caucasian and Asian population. All the results are listed in Table [2](#T2){ref-type="table"}.

Sensitivity analysis {#s2_4}
--------------------

Sensitivity analysis of the summary odds ratio coefficients on the relationship of the SNP and the risk of IBS is computed by omitting each study in turn. The corresponding pooled ORs were not significantly altered after excluding each eligible study at a time (Figure [5](#F5){ref-type="fig"}).

![Sensitivity analysis of the association of *GNβ3* C825T and IBS in the different genetic models\
(**A**) Allele model (C vs. T). (**B**) Codominant model (CC vs. TT). (**C**) Codominant model (CT vs. TT). (**D**) Dominant model (CC + CT vs. TT). (**E**) Recessive model (CC vs. TT + CT).](oncotarget-09-2770-g005){#F5}

Publication bias {#s2_5}
----------------

No evidence of publication bias was detected regarding the ORs of the SNP in this study by either Begg\'s or Egger\'s test (Table [3](#T3){ref-type="table"}).

###### Publication bias tests for association of the GNβ3 C825T polymorphism with IBS

  Comparisons      Egger test   Begg test                     
  ---------------- ------------ ----------- ----------------- ------
  **GNβ3 C825T**                                              
  C vs. T          0.48         0.80        (--3.70, 4.67 )   0.76
  CC vs. TT        --0.96       0.60        (--4.92, 3.01 )   0.64
  CT vs. TT        --0.22       0.87        (--3.02, 2.59 )   0.76
  CC+CT vs. TT     --0.34       0.80        (--3.39, 2.70 )   0.64
  CC vs. CT+TT     0.93         0.59        (--2.75, 4.64 )   0.64

DISCUSSION {#s3}
==========

Recently, several genetic association studies identified a novel association between *GNβ3 C825T* polymorphism and IBS. In Asia, Lee et al. \[[@R10]\] demonstrated that *GNβ3* 825T allele is associated with IBS in Koreans, especially among IBS with constipation. Likewise, Park et al. \[[@R12]\] found that the TT genotype of *GNβ3* C825T is common in IBS-C while the CC genotype is common in IBS-D. In Europe, Markoutsaki T \[[@R11]\] found that TT genotype and T allele of *GNβ3* are significantly associated with IBS predisposition in Greeks. Besides, in a Netherlands study CT genotype of *GNβ3* showed significant association with IBS \[[@R9]\]. However, other studies \[[@R24]--[@R30]\] revealed that the *GNβ3* C825T polymorphism may be not associated with the development of IBS or its subtypes. Generally, this disparity might be partly due to ethnic differences or to the limited numbers of subjects involved in the studies. To derive a more precise estimation of this association, we performed a meta-analysis to clarify the associations between the *GNβ3* C825T mutation and the presence of IBS and its subtypes. Eleven case-control studies \[[@R9]--[@R12], [@R24]--[@R30]\] with a total of 1,422 IBS patients and 2,073 healthy controls were included in our meta-analysis, which was sufficiently powered to detect IBS susceptibility associated with *GNβ3* C825T gene polymorphism.

In the present study, we used four models to estimate the relationship between *GNB3* C825T polymorphism and IBS and its subtypes. The C allele of *GNβ3* C825T was demonstrated to be significantly associated with a decreased risk of IBS-C in allele model. While the results of the recessive model supported CC genotype of *GNβ3* could increase the risk of IBS-D. Additionally, subgroup analyses by ethnicity indicated that the SNP of *GNβ3* C825T was only significantly associated with a decreased risk of IBS-C in Asian population, while the CC genotype was only associated with increased IBS-D risk in the Asian population. Besides that, neither the overall results with the whole population nor the subgroup analysis by Asian and Caucasian ethnicity indicated the associations between *GNβ3* C825T polymorphism and the development of IBS and IBS-M. Obviously, our results are not consistent with some previous studies \[[@R9]--[@R12]\] that *GNβ3* C825T was associated with IBS. A possible explanation for this phenomenon is that the previous single studies of IBS had small samples size, and thus the significance of current work may not be justified; thus, further studies are needed to clarify the effects of this SNP on the development of IBS and its subtypes. In addition, the differential allele frequencies of the SNP exerted disproportionate levels of influence on the IBS risks in different populations. For example, the minor allele frequencies (MAF) of the SNP *GNβ3* C825T (rs5443) is 0.50 in the East Asian population (EAS), whereas the MAF is 0.31 in the European population (EUR) and the MAF is 0.38 in the Ad Mixed American population (AMR) based on the data from the 1000 G. In accordance with our partial findings, a previous meta-analysis performed by Pan ZG et al. \[[@R31]\] found that no associations of GNB3 C825T polymorphism with IBS risk either in Asian population or Caucasian population. However, that previous meta-analysis based on seven studies still had some differences from our results, and suggested that no significant associations between *GNβ3* C825T polymorphism and 3 IBS subtypes (IBS-C, IBS-D and IBS-M). The major reason of this discrepancy is that this previous meta-analysis did not include all the published articles and did not assess the association between this polymorphism and IBS subtypes with respect to ethnicity. In contrast, our meta-analysis included all the eleven relevant published studies with a larger sample size of cases and controls, which gave a greater statistical power to evaluate the association than the previous study. Additionally, our study included four studies in Asian group and four studies in Caucasian group to evaluate the association between *GNβ3* C825T polymorphism and IBS subtypes, which gave a more detailed analysis to assay the association and showed a more reliable result.

To the best of our knowledge, this is the first meta-analysis to explore the relationships between *GNβ3* C825T gene polymorphism and IBS and its subtypes with respect to ethnicity. The genotype distributions in all of the controls were consistent with HWE, except one for one study reported by Lee et al. \[[@R10]\]. However, the association was not significant change when excluded the study. The NOS results indicated that the included studies were credible. Moreover, sensitivity analysis did not significantly alter in overall and subgroup results under all genetic models. In addition, no evidence of publication bias was identified by either Begg\'s or Egger\'s tests. Taken together, the outcomes of our meta-analysis are relatively reliable and stable.

Nevertheless, there were some limitations in the current study. First, only articles in English and Chinese language were included; thus, studies written in other languages were neglected. Second, although we performed a systematic searching strategy to identify eligible studies, there was still probability that few studies so called "grey literatures" were not included. Third, due to the limited data, we did not carry out subgroup analysis to other factors, which may participate in the progression of IBS, such as age, infection, social psychology, and other living habits. Finally, IBS is a common gastrointestinal disorder in the human population; particularly in females (two thirds of patients are female). However, none of the original studies accounted for gene-gender interactions. Further studies are needed to clarify whether gender-related differences affected the polymorphism of *GNβ3* C825T and subsequent IBS.

In summary, this meta-analysis suggested that the C allele of *GNβ3* C825T may be associated with a decreased risk of IBS-C, while the CC genotype of *GNβ3* may be associated with increased IBS-D risk. However, due to the above-mentioned limitations, a well-designed large-scale study that includes ethnicities, IBS subtypes and psychosocial factors is required to confirm the findings of the current meta-analysis.

MATERIALS AND METHODS {#s4}
=====================

Search strategy and selection criteria {#s4_1}
--------------------------------------

According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement \[[@R32]\], we searched the related literature of the electronic records of the PubMed, Embase, Science Direct, Chinese National Knowledge Infrastructure (CNKI) and WANFANG databases prior to April 2017. The search terms included the following key words: ("Irritable bowel syndrome" *or* "IBS") AND ("polymorphism" *or* "allele" *or* "gene" *or* "mutation" *or* "variant") AND ("G protein beta3" or "G protein *β3*" or "*GNβ3*"). Furthermore, the references of all retrieved articles were also checked by hand to identify additional potential studies. The languages were limited to English and Chinese. We inclusion all studies that (1) evaluated the association between *GNβ3* polymorphism and the risk of IBS; (2) used a case control design; (3) provided sufficient data of allele and genotype frequencies of SNPs or required information could be calculated; and (4) if serial studies on the same population were published, only the most recent or the largest research study was included. Additionally, we excluded reviews, abstracts, and redundant and animal studies.

Data extraction {#s4_2}
---------------

Two independent investigators extracted relevant data from all included studies on the basis of the inclusion criteria, and a third investigator verified them. The following information was extracted from all of enrolled studies: the surname of the first author, publication year, country of origin, ethnicity, sample size, genotyping method, and the *GNβ3* genotype distributions and alleles in the case and control groups.

Quality assessment {#s4_3}
------------------

The quality of included studies were assessed by two investigators independently on the basis of Newcastle-Ottawa Scale (NOS) \[[@R33]\], which based on three aspects: selection, comparability and exposure. Studies with a score of 5 points or higher were considered to be of high quality.

Statistical analysis {#s4_4}
--------------------

The HWE of the genotype distributions in the controls of the include studies were tested by the Chi-square test, *P* \< 0.05 was considered statistically significant. Studies with the controls not in HWE were subjected to a sensitivity analysis \[[@R34]\]. The power analysis was calculated by using the Power and Sample Size Program software \[[@R35]\]. The associations of the *GNβ3* polymorphism with the risk of IBS was assessed by the pooled ORs with the corresponding 95% CIs under the following genetic models: allele model (C vs. T), codominant model (CC vs. TT and CT vs. TT), dominant model (CC + CT vs. TT), and recessive model (CC vs. CT + TT). The heterogeneity between studies was determined by the Cochrane\'s *Q*-statistic test \[[@R36]\], and the inconsistency was quantified with the *I*^2^ statistic. When *I*^2^ \> 50% or *P*~Q~ ≤ 0.1, which suggest substantial heterogeneity, a random-effects model (DerSimonian-Laird method) \[[@R37]\] was used; otherwise, the fixed-effects model (Mantel-Haenszel method) \[[@R32]\] was applied. Sensitivity analysis was conducted by sequentially omitting each study to evaluate the stability of statistical results. Furthermore, Begg\'s funnel plot and Egger\'s test \[[@R38]\] was used to evaluate the potential publication bias (*P* \< 0.05 was considered statistically significant). All analyses were conducted using the STATA 12.0 software packages.
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:   constipation predominant IBS
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